Medicare to Negotiate Prices for 15 Popular Drugs

The Biden administration announced that 15 commonly used drugs, including Ozempic and Wegovy, will be included in Medicare's price negotiation program. This marks the first time the U.S. government will directly negotiate drug prices with manufacturers, and is expected to save taxpayers billions of dollars. While Ozempic and Wegovy have drawn scrutiny for their high costs, Medicare currently only covers them for diabetes treatment, not weight loss. The incoming Trump administration will decide whether to implement a proposed rule to cover these medications for obesity. This brings the total number of drugs subject to Medicare price negotiations to 25, covering a third of prescription drug spending. The pharmaceutical industry has sued over the program, but groups like the AARP say they will fight to uphold the law.